Colorectal Cancer
Conditions
Brief summary
Colorectal cancer is one of the most common cancers in Malaysia and worldwide. Although it can often be prevented or treated successfully when detected early, many people in Malaysia are diagnosed at an advanced stage. Screening tests, such as the immunochemical faecal occult blood test (iFOBT), can help detect early signs of colorectal cancer; however, participation in screening remains low. Community pharmacies are easily accessible healthcare settings where people frequently seek health advice. Pharmacists may play an important role in improving awareness and encouraging colorectal cancer screening by providing education and support. However, more information is needed to understand how people perceive and respond to pharmacy-based colorectal cancer screening.
Interventions
Campaign Components The one-day Ribbon of Hope campaign will be implemented at each intervention pharmacy to promote colorectal cancer awareness and screening uptake. The campaign consists of educational materials and one-on-one education about colorectal cancer.
Sponsors
Study design
Eligibility
Inclusion criteria
* Adults aged 50 to 75 years * Visiting participating community pharmacies during the study period * Able to provide informed consent * Willing to complete the study questionnaire * Willing to provide consent for follow-up assessment of: iFOBT provision, iFOBT testing completion, iFOBT results
Exclusion criteria
* Previous diagnosis of colorectal cancer * History of colonoscopy within the recommended screening interval (within past 1 year) * Currently experiencing symptoms suggestive of colorectal cancer * Having a first-degree relative diagnosed with colorectal cancer
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Beliefs and perceptions toward colorectal cancer and iFOBT screening | From enrollment to the 8th week follow-up. | Beliefs and perceptions toward colorectal cancer and iFOBT screening, measured using the Champion Health Belief Model Scale - Colorectal Cancer - Malay (CHBMS-CRC-M) subscales of perceived susceptibility, perceived benefits, and perceived barriers, between customers from pharmacies with and without the one-day awareness campaign. Each item is rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Domain scores will be calculated by summing (or averaging) the items within each domain, with higher scores indicating greater perceived susceptibility, benefits or barriers. |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of participants who were willing to accept and perform iFOBT, report iFOBT results, and follow-up if needed. | From enrollment to the 8th week of follow-up |
Countries
Malaysia